HDAC9 and neoplasm: Pharmacodynamic effects of HDAC inhibition, such as histone H3 hyperacetylation in peripheral blood mononuclear cells (PBMCs), and the induction of p21 and decreased Ki67 staining in tumor samples, were observed in seven pre- and post-treatment sample pairs, which confirmed the biological effect of romidepsin.